Mass Tort News6 min readNew GLP-1 Pill Approved as Ozempic MDL Nears TrialFDA approves Eli Lilly's Foundayo — the first oral GLP-1 with no fasting requirement — as 3,363 pending GLP-1 lawsuits approach critical deadlines.mass tortGLP-1Ozempic+2Apr 7, 2026Read
Legal Updates7 min readFDA Warns Novo Nordisk on Unreported DeathsFDA cites 'systemic failures' in Novo Nordisk's adverse event reporting for Ozempic and Wegovy, including unreported patient deaths.OzempicFDAmass tort+2Mar 24, 2026Read
Mass Tort News6 min read4,400 GLP-1 Lawsuits Filed: What Firms Need to KnowGLP-1 drug lawsuits surged 130% in 2025, with 75% alleging gastroparesis. Bellwether trials expected mid-2026.mass tortGLP-1Ozempic+2Feb 3, 2026Read
